Results 191 to 200 of about 7,838 (234)
Some of the next articles are maybe not open access.
Diabetes Technology & Therapeutics
Objective: To evaluate the safety and explore the efficacy of use of ultra-rapid lispro (URLi, Lyumjev) insulin in the Tandem t:slim X2 insulin pump with Control-IQ 1.5 technology in children, teenagers, and adults living with type 1 diabetes (T1D ...
Carol J. Levy +20 more
semanticscholar +1 more source
Objective: To evaluate the safety and explore the efficacy of use of ultra-rapid lispro (URLi, Lyumjev) insulin in the Tandem t:slim X2 insulin pump with Control-IQ 1.5 technology in children, teenagers, and adults living with type 1 diabetes (T1D ...
Carol J. Levy +20 more
semanticscholar +1 more source
Diabetes, 2021
URLi is a novel insulin lispro formulation developed to more closely match physiological insulin secretion. This randomized, subject-blind, 3‑period, crossover, 10‑h euglycemic clamp study assessed the pharmacokinetics (PK), glucodynamics (GD) and ...
Ye-Rong Yu +6 more
semanticscholar +1 more source
URLi is a novel insulin lispro formulation developed to more closely match physiological insulin secretion. This randomized, subject-blind, 3‑period, crossover, 10‑h euglycemic clamp study assessed the pharmacokinetics (PK), glucodynamics (GD) and ...
Ye-Rong Yu +6 more
semanticscholar +1 more source
American Journal of Veterinary Research, 2020
OBJECTIVE To assess effects of basal-bolus insulin treatment (BBIT) with lispro and neutral protamine Hagedorn (NPH) insulins, compared with NPH insulin alone, on serum fructosamine concentration (SFC) and postprandial blood glucose concentration (BGC ...
A. Bertalan, K. Drobatz, R. Hess
semanticscholar +1 more source
OBJECTIVE To assess effects of basal-bolus insulin treatment (BBIT) with lispro and neutral protamine Hagedorn (NPH) insulins, compared with NPH insulin alone, on serum fructosamine concentration (SFC) and postprandial blood glucose concentration (BGC ...
A. Bertalan, K. Drobatz, R. Hess
semanticscholar +1 more source
Pharmazie, 2020
Two capillary electrophoresis (CE) methods have been developed for the separation of charge and mass variants of human insulin and its recombinant analogue lispro.
B. Pajaziti +3 more
semanticscholar +1 more source
Two capillary electrophoresis (CE) methods have been developed for the separation of charge and mass variants of human insulin and its recombinant analogue lispro.
B. Pajaziti +3 more
semanticscholar +1 more source
Diabetes, obesity and metabolism, 2019
We investigated the pharmacodynamics (PD) and pharmacokinetics (PK) of BioChaperone insulin Lispro (BCLIS), faster insulin aspart (FIA) and insulin aspart (ASP) in patients with type 1 diabetes using an insulin pump.
T. Heise +12 more
semanticscholar +1 more source
We investigated the pharmacodynamics (PD) and pharmacokinetics (PK) of BioChaperone insulin Lispro (BCLIS), faster insulin aspart (FIA) and insulin aspart (ASP) in patients with type 1 diabetes using an insulin pump.
T. Heise +12 more
semanticscholar +1 more source
Nihon rinsho. Japanese journal of clinical medicine, 2002
The results of the clinical studies of insulin lispro carried out in Japan to confirm the pharmacodynamics, pharmacokinetics, efficacy and safety, which were recently released were summarized in this article. When compared to human regular insulin, single subcutaneous injection to healthy persons showed that insulin lispro was adsorbed and disappeared ...
openaire +2 more sources
The results of the clinical studies of insulin lispro carried out in Japan to confirm the pharmacodynamics, pharmacokinetics, efficacy and safety, which were recently released were summarized in this article. When compared to human regular insulin, single subcutaneous injection to healthy persons showed that insulin lispro was adsorbed and disappeared ...
openaire +2 more sources

